International outlets are interested in Egypt turning into a global affordable destination for those seeking Hepatitis C treatment. Egypt has been producing the treatment Sovaldi since 2015 since 2015 under a government-sponsored initiative that has lowered the price of a full course of treatment to around USD 83 from around USD 84,000, the website claims. The treatment was developed by the US-based Gilead in 2013, but under the Tour N’ Cure initiative, Egypt’s government is able to offer the treatment to patients for about 8% of its cost, which means that patients from all countries come to Egypt for treatment, campaign director Mostafa El Sayed says.

Tags: